Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesClinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas
Modern Pathology, 10/28/09
Dacic S et al. – The cost–effectiveness of lung carcinoma mutational testing would be improved by initial determination of KRAS mutational status as negative predictor of the patient's response to EGFR tyrosine kinase inhibitors, followed by EGFR mutational analysis, if necessary.
Related Articles
Diagnostic Efficacy of PET/CT Plus Brain MR Imaging for Detection of Extrathoracic Metastases in Patients with Lung Adenocarcinoma
Journal of Korean Medical Science, 11/16/09
Relevance Score: 69%
Use of EGFR/KRAS Mutation Testing To Define Clonal Relationships Among Multiple Lung Adenocarcinomas
Chest, 10/08/09
Relevance Score: 69%
Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas
Lung Cancer, 11/06/09
Relevance Score: 68%
Lung Adenocarcinoma with EGFR Amplification Has Distinct Clinicopathologic and Molecular Features in Never-Smokers
Cancer Research, 11/02/09
Relevance Score: 68%
An Embryonic Stem Cell–Like Signature Identifies Poorly Differentiated Lung Adenocarcinoma but not Squamous Cell Carcinoma
Clinical Cancer Research, 10/12/09
Relevance Score: 68%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with Non–Small Cell Lung Cancer from Patients with Nonmalignant Lung Disease
Cancer Research, 12/20/09
A small-cell lung cancer genome with complex signatures of tobacco exposure
Nature, 12/18/09
CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients
British Journal of Cancer, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor